open access

Vol 11, No 4 (2016)
Review paper
Published online: 2016-09-13
Get Citation

2015 European Society of Cardiology (ESC) guidelines for the management of infective endocarditis - what has changed since 2009?

Tomasz Zapolski, Agnieszka Styczeń, Andrzej Wysokiński
DOI: 10.5603/FC.2016.0050
·
Folia Cardiologica 2016;11(4):293-302.

open access

Vol 11, No 4 (2016)
Review Papers
Published online: 2016-09-13

Abstract

Infective endocarditis (IE) constitutes a rather rare disease, belonging to dangerous, not infrequently lethal illnesses of cardiovascular system. Adequate IE diagnosis is regarded as one of the most complicated in medicine. Diagnostic and therapeutic difficulties in infective endocarditis arise from non – homogeneity of the disease, frequent imitating other illnesses on the basis of presented clinical symptoms and the insidiousness of IE course resulting in serious complications.

On the grounds of that there exists a constant necessity of precise data concerning IE treatment verification by a panel of experts, as well as constructive assessment of diagnostic and therapeutic procedures. The latest guidelines of European Society of Cardiology (ESC) Task Force Members on prevention, diagnosis and treatment of infective endocarditis were published in 2009. The year 2015 has brought their upgrade.

This review presents differences between the guidelines from the year 2009 and the year 2015, with special consideration of current emphasis on multidisciplinary approach in patients diagnosed with IE (Endocarditis Team) and outlining changes in those patients’ treatment in the context of fast progress in the field of cardiology, that has been made lately.

Abstract

Infective endocarditis (IE) constitutes a rather rare disease, belonging to dangerous, not infrequently lethal illnesses of cardiovascular system. Adequate IE diagnosis is regarded as one of the most complicated in medicine. Diagnostic and therapeutic difficulties in infective endocarditis arise from non – homogeneity of the disease, frequent imitating other illnesses on the basis of presented clinical symptoms and the insidiousness of IE course resulting in serious complications.

On the grounds of that there exists a constant necessity of precise data concerning IE treatment verification by a panel of experts, as well as constructive assessment of diagnostic and therapeutic procedures. The latest guidelines of European Society of Cardiology (ESC) Task Force Members on prevention, diagnosis and treatment of infective endocarditis were published in 2009. The year 2015 has brought their upgrade.

This review presents differences between the guidelines from the year 2009 and the year 2015, with special consideration of current emphasis on multidisciplinary approach in patients diagnosed with IE (Endocarditis Team) and outlining changes in those patients’ treatment in the context of fast progress in the field of cardiology, that has been made lately.

Get Citation

Keywords

endocarditis, guidelines, endocarditis team

About this article
Title

2015 European Society of Cardiology (ESC) guidelines for the management of infective endocarditis - what has changed since 2009?

Journal

Folia Cardiologica

Issue

Vol 11, No 4 (2016)

Article type

Review paper

Pages

293-302

Published online

2016-09-13

DOI

10.5603/FC.2016.0050

Bibliographic record

Folia Cardiologica 2016;11(4):293-302.

Keywords

endocarditis
guidelines
endocarditis team

Authors

Tomasz Zapolski
Agnieszka Styczeń
Andrzej Wysokiński

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl